3 insiders bought €60k of shares over the last 90 days, the latest by Gendel Mitchell, filed 07 Aug 2026.
Tilray Brands, Inc., classified in the Health Care sector, is a listed company based in Nanaimo, Canada, founded in 2013. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 24 October 2026, brought 46 filings signed by 10 insiders.
The record shows 3 purchases on the open market worth €60k, made by 3 insiders, against 1 sale worth €198k by 1 insider. On balance, insiders were net sellers of €138k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a sale of €198k from Hopkinson David G., disclosed on 22 April 2026, or 0.038% of market capitalisation. Those buying include 2 senior executives and 1 finance chief.
The data flag 3 purchases as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 7 August 2026, 77 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction.
With 46 filings in twelve months, the company is more active than the median of 24 filings across the 3,167 companies we follow on the same exchange. The full history, which starts in 2018, counts 15 purchases against 75 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 May 2026), the company reported revenue of 915.5 m USD and net income of -121.4 m USD.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Tilray Brands, Inc. Buy (bullish), based on 9 analysts. Average price target: US$5.89.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended May 2026 · cache
25 of 526 declarations
Tilray Brands, Inc. is a company focused on the production and distribution of cannabis-based products. It primarily operates in the U.S. and Canadian markets.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Nanaimo, Canada · Founded: 2013 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| May 2026 | 915.5 m USD | -121.4 m USD | -1.09 USD | 10-K |
| May 2025 | 821.3 m USD | -2.19 bn USD | -24.56 USD | 10-K |
| May 2024 | 788.9 m USD | -245.0 m USD | -3.30 USD | 10-K |
| May 2023 | 627.1 m USD | -1.45 bn USD | -2.35 USD | 10-K |
| May 2022 | 628.4 m USD | -476.8 m USD | -0.99 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.